Gadolinium Survey adolinium Survey

0 downloads 0 Views 78KB Size Report
gent(s) do you use in clinical practice (check all that apply) ? * tetatedimeglumine (Magnevist) ide (Omniscan) etamide (OptiMARK) atedimeglumine (MultiHance).
Gadolinium Survey * Required 1. Are you a radiologist or cardiologist ? * x

Radiologist

x

Cardiologist

2. How many pediatric cardiac MRI studies do you perform in a year ? * x

Less than 50

x

50 - 100

x

100 - 200

x

200 - 500

x

More than 500

3. What setting do you work in ? * x

Tertiary care center

x

Community hospital

x

Private practice

4. Which country do you work in? * 5. Which gadolinium agent(s) do you use in clinical practice (check all that apply) ? * x

Gadopentetatedimeglumine (Magnevist)

x

Gadodiamide (Omniscan)

x

Gadoversetamide (OptiMARK)

x

Gadobenatedimeglumine (MultiH (MultiHance)

x

Gadobutrol (Gadovist)

x

Gadofosveset (Ablavar (Ablavar)

x

Gadoteridol (ProHance)

x

Gadoterate (Dotarem)

x

Other:

6. Which single contrast agent do you most commonly use (check one) ? * x

Gadopentetatedimeglumine (Magnevist)

x

Gadodiamide (Omniscan)

x

Gadoversetamide (OptiMARK)

x

Gadobenatedimeglumine benatedimeglumine (MultiH (MultiHance)

x

Gadobutrol (Gadovist)

x

Gadofosveset (Ablavar (Ablavar)

x

Gadoteridol (ProHance)

x

Gadoterate (Dotarem)

x

Other:

7. What are your reasons for using this particular agent (question 6) over others in your practice (check all that apply) ? * x

Image quality

x

Price

x

Availability

x

Approval by pharmaceutical licensi licensing ng body that most closely matches my indications

x

Side effect profile

x

Other:

8. What is the single most important reason for using this particular agent over others in your practice (check only one) ? * x

Image quality

x

Price

x

Availability (e.g., hospital contract with manufacturer)

x

Approval by pharmaceutical licensing body that most closely matches my indications

x

Side effect profile

x

Other:

9. Do you perform scans in neonates < 1 week ? (If no, please go to question 13) * x

Yes

x

No

10. If you answered "yes" to question 9, do you use gadolinium in neonates < 1 week ? (If no, please go to question 13) x

Yes

x

No

11. If you answered "yes" to question 10, which gadolinium agent(s) do you use in neonates < 1 week ? x

Gadopentetatedimeglumine glumine (Magnevist)

x

Gadodiamide (Omniscan)

x

Gadoversetamide (OptiMARK)

x

Gadobenatedimeglumine (MultiH (MultiHance)

x

Gadobutrol (Gadovist)

x

Gadofosveset (Ablavar Ablavar)

x

Gadoteridol (ProHance)

x

Gadoterate (Dotarem)

x

Other:

12. Does / do this / these gadolinium agent(s) differ from one(s) used in older children and adolescents ? x

Yes

x

No

13. Which single method do you primarily use to assess renal function in neonates < 1 week ? * x

Serum creatinine

x

Glomerular filtration rate (GFR, Schwartz formula)

x

Urine output

x

Other:

14. Do you estimate GFR (based on serum creatinine) in none, some or all of your patients ? * x

None

x

Some

x

All

15. If your answer to the previous question was “some”, in whom do you obtain a creatinine to calculate GFR ?(check all that apply) x

All neonates

x

All patients < 1 week of age

x

All patients with active renal disease and / or impaired renal function

x

Patients with impaired renal function in the past

x

Patients with a risk factor for impaired renal function (vasculitis, arteriopathies), but no known renal dysfunction

16. Please check all that apply: Inn patients with GFR 60ml/kg/1.73m2

x

Other:

17. Please check all that apply: In patients wit with GFR between 30 and 60ml/kg/1.73m2, * x

I give gadolinium, but use a specific agent (Please indicate agent in question 18)

x

I give gadolinium, but never “double dose”

x

I do not administer gadolinium at all

x

My practice is unchanged as compared to a GFR > 60ml/kg/1.73m2

x

Other:

18. If you selected "I give gadoliniu gadolinium, m, but use a specific agent" for questions 16 or 17, please indicate the agent used x

Gadopentetatedimeglumine (Magnevist)

x

Gadodiamide (Omniscan)

x

Gadoversetamide (OptiMARK)

x

Gadobenatedimeglumine (MultiH (MultiHance)

x

Gadobutrol (Gadovist)

x

Gadofosveset (Ablavar (Ablavar)

x

Gadoteridol (ProHance)

x

Gadoterate (Dotarem)

x

Other:

19. Do you obtain written consent before administering gadolinium? * x

Never

x

Sometimes

x

Most of the time

x

Always

20. What is the single most common side effect of gadolinium in your experience * x

Rash

x

Nausea / Emesis

x

Light-headedness

x

Headache

x

Bronchospasm

x

Discomfort at injection site

21. How frequently do you encounter one or more side effects attributable to gadolinium ? * x

Never

x

Rarely (1-5% 5% of cases)

x

Sometimes (5-20% 20% of cases)

x

Frequently (>20% 20% of cases)

Comments [Optional]